Promoter holding
64.27%
IC
Innova Captab Limited - Due diligence report
A 360° intelligence report on Innova Captab: trust score, financial health, credit view, compliance, directors, growth and distress signals …
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Innova Captab — 360° Intelligence Report
Generated from MCA filings & public records84/100
Trust Score
Low Risk
Innova Captab is assessed as Low Risk with a Trust Score of 84/100. Innova Captab is an active public limited indian non-government company incorporated in 2005, operating in the Chemicals sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 25 Jul 2026 from the latest processed filings. Innova Captab Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
84/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
62/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
- Moderate gearing (D/E 38%).
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (A-).
Charges position: 5 open (427.25 cr) · 12 satisfied (158.40 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 3 | 48.0 cr |
| State Bank Of India | 2 | 48.0 cr |
| Yes Bank Limited | 6 | 48.0 cr |
| The Hongkong And Shanghai Banking Corporation Limited | 2 | 48.0 cr |
| Axis Bank | 2 | 48.0 cr |
| Axis Bank Limited | 1 | 48.0 cr |
Compliance Score: 62/100 Moderate
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 3 court forum(s).
- 1 auditor resignation(s) filed - latest: GARG SANJEEV & ASSOCIATES on 2021-05-05.
- Delayed payments to MSME suppliers disclosed (2 disclosure(s)).
- 7 active GST registration(s).
Legal cases on record (3)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ARCHIT AGGARWAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUDHIR KUMAR BASSI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHIRISH GUNDOPANT BELAPURE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRIYANKA DIXIT | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MANOJ KUMAR LOHARIWALA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VINAY KUMAR LOHARIWALA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MAHENDAR KORTHIWADA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| JAYANT VASUDEO RAO | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Lokesh Bhasin | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Neeharika Shukla | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 10 directors on the board.
- No disqualified or deactivated DINs.
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
2
Group entities
2
Capital events
1 allotment(s) · 1 transfer(s)
Promoters hold a minority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Sharon Bio Medicine Limited | Subsidiary Company | 74.00% |
| Univentis Medicare Limited | Subsidiary Company | 74.00% |
Key managerial personnel: MANOJ KUMAR LOHARIWALA (Whole-time director) · VINAY KUMAR LOHARIWALA (Managing Director) · JAYANT VASUDEO RAO (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 90 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
Operating for 21+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
5 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 4.31 Lakh.
3 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence77/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment82/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 5 open charge(s) of 427.25 cr already registered.
- Compliance gaps should be priced into terms.
Investor view90/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 4 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events31 Jul 2025
Last AGM held
Annual general meeting
28 Jul 2025
Charge created
Hdfc Bank Limited - 52.32 cr
31 Mar 2025
Latest balance sheet
Filed with ROC
22 May 2024
Charge satisfied
The Hongkong And Shanghai Banking Corporation Limited
25 Apr 2024
Director appointed
Lokesh Bhasin (Cfo)
29 Mar 2024
Director ceased
Gaurav Srivastava
26 Apr 2023
Director ceased
RISHI GUPTA
01 Mar 2023
Charge satisfied
Yes Bank Limited
27 Dec 2022
Charge satisfied
Yes Bank Limited
04 Oct 2022
Charge satisfied
Yes Bank Limited
29 Sep 2022
Charge created
Hdfc Bank Limited - 150.00 cr
Charge created
Hdfc Bank Limited - 20.00 cr
19 Jul 2022
Securities allotted
1412430 Preference Shares - 50.00 cr raised
09 May 2022
Director appointed
Neeharika Shukla (Company Secretary)
04 Apr 2022
Director ceased
ARCHIT AGGARWAL
10
Key Observations
Auto-generated from the data aboveRevenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
10 active director(s) / partner(s); board looks stable and experienced.
7 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 2 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of A- from Care.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Procter & Gamble Health | L99999MH1967PLC013726 | Mumbai, Maharashtra, India |
| Dharmaj Crop Guard | L24100GJ2015PLC081941 | Ahmedabad, Gujarat, India |
| Orchid Pharma | L24222TN1992PLC022994 | Chengalpattu, Tamil Nadu, India |
| Cleanscience | L24114PN2003PLC018532 | Pune City, Maharashtra, India |
| Bajaj | L01110RJ2006PLC047173 | Udaipur, Rajasthan, India |
| Viswaat | U24100MH1996PLC100815 | Mumbai, Maharashtra, India |
| Sakthi Sugars | L15421TZ1961PLC000396 | Erode District, Tamil Nadu, India |
| Maiz Products | L99999GJ1941PLC000471 | Ahmedabad, Gujarat, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Innova Captab before audits and certifications: compliance score 62/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Innova Captab: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Innova Captab - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 84/100, distress signals and MSME payment-delay disclosures - know whether Innova Captab pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Innova Captab - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Innova Captab an active company?
Innova Captab has MCA status “Active” with a compliance score of 62/100 (Moderate).
Is Innova Captab financially healthy?
Innova Captab has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Innova Captab?
Its overall Trust Score is 84/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Innova Captab?
Promoters hold a minority stake - exact percentages are in the full report. 10 active director(s) are on record.
Does Innova Captab have loans or charges against its assets?
5 open charge(s) are registered against its assets, and 12 earlier charge(s) stand satisfied.
Is Innova Captab up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 62/100 (Moderate).
Is it risky to lend to Innova Captab?
Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
